Skip to main content

Table 3 A summary of studies examining the outcomes of transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR) in dialysis patients

From: A 91-year-old woman with severe aortic stenosis successfully underwent maintenance hemodialysis via arteriovenous fistula after transcatheter aortic valve implantation: a case report with literature review

Study/countryDesignN*Mean age ± SDShort-term outcome (%)Long-term outcome (%)Reference
Szerlip M et al. 2019/USAProspective305376In-hospital mortality (5.1)
1-year mortality (36.8)
 [25]
Schymik et al. 2019/GermanyProspective5676.6 ± 6.4Perioperative mortality (10.7)
1-year survival (57.1)
3-year survival (26.8)[23]
Al-Rashid et al. 2017/GermanyRetrospective2279 ± 530-day mortality (4.5)2-year mortality (53)[5]
Bhatia et al. 2017/USARetrospective170875.3 ± 9.9In-hospital mortality (8.2) [26]
Szerlip et al. 2016/USARetrospective4376.2 ± 11Operative mortality (14) 6-month mortality (25.6) [27]
Maeda et al. 2015/JapanProspective1776.7 ± 51-year overall mortality (0) [16]
Dumonteil et al. 2013/France, the Netherlands, ItalyRetrospective3376.1 ± 7.330-day all-cause mortality (15.2)
1-year survival (54.8)
 [28]
Rau et al. 2012/GermanyRetrospective1072.3 ± 6430-day overall mortality (0) [29]
  1. *Number of dialysis patients. Only dialysis patients were depicted from each study